![Nick Taylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nick Taylor
Plus aucun poste en cours
Profil
Nick Taylor is the founder of Locus Biosciences, Inc. which was founded in 2015.
Anciens postes connus de Nick Taylor
Sociétés | Poste | Fin |
---|---|---|
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |